Skip to main content

Table 3 Median (inter-quartile range) levels of iFGF23, cFGF23, hepcidin, ferritin and phosphate at Day 0 and Day 2, according to randomized treatment group

From: Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial

 

Ferric carboxymaltose (n = 22)

 

Iron sucrose (n = 20)

 
 

Day 0

Day 2

P

Day 0

Day 2

P

iFGF23 (pg/mL)

843 (313–1922)

576 (356–1296)

0.046

381 (245–1526)

378 (235–1584)

0.77

cFGF23 (RU/mL)

704 (475–1204)

813 (267–1156)

0.036

710 (448–1548)

646 (307–1576)

0.23

Ferritin (μg/L)

198 (129–276)

327 (281–472)

<0.001

191 (77–237)

370 (218–475)

<0.001

Hepcidin (ng/mL)

7.8 (2.7–12.6)

21.4 (13.9–26.2)

<0.001

3.4 (2.7–8.8)

12.2 (7.3–19.2)

<0.001

Phosphate (mmol/L)

1.53 (1.14–1.71)

1.37 (1.05–1.67)

0.030

1.29 (1.11–1.65)

1.34 (1.08–1.54)

0.089